FingerTango Inc. (HKG:6860)
0.2310
+0.0010 (0.43%)
Aug 13, 2025, 4:08 PM HKT
Oncternal Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 32.84 | 6.77 | -139.35 | -517.4 | 127.64 | Upgrade |
Depreciation & Amortization | 19.2 | 15.58 | 16.24 | 21.45 | 17.96 | Upgrade |
Loss (Gain) From Sale of Assets | 0.58 | 0.7 | 0.02 | 0.21 | 0.07 | Upgrade |
Asset Writedown & Restructuring Costs | -9.03 | -0.94 | 9.9 | 30.25 | 25.36 | Upgrade |
Loss (Gain) From Sale of Investments | 2.27 | -9.39 | 61 | 0.7 | -6.02 | Upgrade |
Stock-Based Compensation | - | - | - | 1.8 | 8.17 | Upgrade |
Provision & Write-off of Bad Debts | 0.5 | -2.09 | -3.83 | 6.42 | 0.12 | Upgrade |
Other Operating Activities | -20.08 | -46.33 | 54.91 | 521.26 | 17.98 | Upgrade |
Change in Accounts Receivable | 46.11 | -11.35 | 13.08 | -29.88 | 21.94 | Upgrade |
Change in Accounts Payable | -0.67 | -16.64 | 10.44 | 11.89 | -29.97 | Upgrade |
Change in Unearned Revenue | -11.31 | -2.87 | -20.63 | 1.42 | -37.76 | Upgrade |
Change in Other Net Operating Assets | -19.42 | 20.47 | 26.21 | 62.6 | -223.7 | Upgrade |
Operating Cash Flow | 41 | -46.09 | 28 | 110.72 | -78.23 | Upgrade |
Operating Cash Flow Growth | - | - | -74.71% | - | - | Upgrade |
Capital Expenditures | -3.89 | -4.56 | -10.04 | -8.54 | -6.8 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0.06 | 0.27 | 0.02 | Upgrade |
Sale (Purchase) of Intangibles | -33.39 | -1.37 | -5.75 | -4.59 | -1.96 | Upgrade |
Investment in Securities | -189.76 | -100 | 53.45 | 11.61 | -143.11 | Upgrade |
Other Investing Activities | - | 2.21 | -2.21 | 1.2 | 9.55 | Upgrade |
Investing Cash Flow | -227.04 | -103.71 | 35.5 | -0.06 | -142.3 | Upgrade |
Long-Term Debt Repaid | -7.38 | -6.37 | -5.9 | -11.81 | -8 | Upgrade |
Net Debt Issued (Repaid) | -7.38 | -6.37 | -5.9 | -11.81 | -8 | Upgrade |
Repurchase of Common Stock | -0.02 | - | - | - | - | Upgrade |
Financing Cash Flow | -7.4 | -6.37 | -5.9 | -11.81 | -8 | Upgrade |
Foreign Exchange Rate Adjustments | 10.99 | 7.89 | 17.16 | -12.35 | -27.89 | Upgrade |
Net Cash Flow | -182.46 | -148.28 | 74.76 | 86.49 | -256.41 | Upgrade |
Free Cash Flow | 37.11 | -50.65 | 17.95 | 102.18 | -85.03 | Upgrade |
Free Cash Flow Growth | - | - | -82.43% | - | - | Upgrade |
Free Cash Flow Margin | 6.09% | -7.84% | 2.16% | 16.67% | -11.36% | Upgrade |
Free Cash Flow Per Share | 0.02 | -0.03 | 0.01 | 0.05 | -0.04 | Upgrade |
Cash Interest Paid | 0.87 | 1.12 | 1.42 | 1.17 | 0.31 | Upgrade |
Cash Income Tax Paid | 12.18 | 10.28 | 7.39 | 11.84 | 10.55 | Upgrade |
Levered Free Cash Flow | -10.41 | -39.48 | 28.03 | 291.11 | -135.8 | Upgrade |
Unlevered Free Cash Flow | -9.87 | -38.78 | 28.92 | 291.84 | -135.6 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.